The atherogenic function of Lp(a) has already been confirmed by genome-wide association studies and meta-analyses of epidemiological studies, which demonstrated a relationship between Lp(a) and cardiovascular diseases (e.g., stoke, myocardial infarction, and calcific aortic valve stenosis) [113,119]. Here, LPA is linked to myocardial infarction.